Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Axonics Inc (NQ: AXNX ) 68.95 +0.02 (+0.03%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Axonics Inc < Previous 1 2 3 4 5 6 7 Next > Axonics Reports Second Quarter 2024 Financial Results August 01, 2024 From Axonics, Inc. Via Business Wire 7 Robotics Stocks That Could Grow Your Wealth July 22, 2024 Explore robotics stocks with the potential to grow investors' wealth as the industry expands across various sectors. Via InvestorPlace Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia May 16, 2024 From Axonics, Inc. Via Business Wire AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024 April 30, 2024 AXNX stock results show that Axonics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace Beyond The Numbers: 7 Analysts Discuss Axonics Stock February 29, 2024 Via Benzinga Analyst Scoreboard: 5 Ratings For Axonics January 09, 2024 Via Benzinga Why Axonics Stock Soared Today January 08, 2024 The medical device maker agreed to be acquired by Boston Scientific. Via The Motley Fool Axonics Reports First Quarter 2024 Financial Results April 30, 2024 From Axonics, Inc. Via Business Wire Boston Scientific Bucks the Medtech Slow Down and Raises Outlook April 30, 2024 Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. Via MarketBeat FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious' April 18, 2024 Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating major... Via Benzinga Exposures Product Safety Axonics Stockholders Approve Merger Agreement with Boston Scientific March 22, 2024 From Axonics, Inc. Via Business Wire Health Care Company Boston Scientific Announces Acquisition of Axonics January 08, 2024 Via Benzinga Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System March 14, 2024 From Axonics, Inc. Via Business Wire Axonics Responds to ITC Action by Medtronic February 29, 2024 From Axonics, Inc. Via Business Wire Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results February 28, 2024 From Axonics, Inc. Via Business Wire AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX February 27, 2024 From Kahn Swick & Foti, LLC Via Business Wire Why Medical Devices Giant Boston Scientific Shares Are Rising Today January 31, 2024 Boston Scientific shares surge in premarket trading following strong Q4 results, beating revenue estimates, amid positive outlook for 2024. Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) January 16, 2024 From Brodsky & Smith LLC Via GlobeNewswire Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review January 12, 2024 The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut. Via Investor's Business Daily Topics ETFs Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling January 11, 2024 The Nasdaq 100 closed higher by more than 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. Via Benzinga 10 Top Stocks With a Strong Buy Rating Right Now January 09, 2024 Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch. Via InvestorPlace BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) January 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire Why Is Crocs (CROX) Stock Up 20% Today? January 08, 2024 Crocs stock is heading higher on Monday with heavy trading of CROX shares after the company posted a strong outlook for 2024! Via InvestorPlace Why Is Axonics (AXNX) Stock Up 20% Today? January 08, 2024 Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific. Via InvestorPlace Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today? January 08, 2024 Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $7 Via Benzinga Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 08, 2024 Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... Via Benzinga J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value January 08, 2024 The year's biggest medical conference kicked off with a melee of buyout news. Via Investor's Business Daily AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders January 08, 2024 From Halper Sadeh LLC Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session January 08, 2024 Via Benzinga Axonics Announces Definitive Agreement to be Acquired by Boston Scientific January 08, 2024 From Axonics, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.